The following is a press release written by Sitav Elturan for Singota Solutions a trusted partner for pharmaceutical development and cGMP sterile drug product manufacturing as well as supply chain services announces the opening of its new facility in Balerna This expansion bolsters Singota’s global presence and demonstrates a commitment to delivering advanced GMP/GDP compliant storage and logistics solutions tailored to the pharmaceutical industry globally the picturesque municipality of Balerna offers Singota’s clients a convenient strategic location touching extensive European rail and road transportation networks The opening of this new Balerna site follows the successful launch in 2024 of Singota’s site near Milan in Rovello Porro Singota’s original European location in Basel Singota’s North American headquarters in Bloomington The new 100,000 square foot facility in Balerna spans three floors and includes a state-of- the-art rooftop solar power system capable of supplementing energy supplied by the regional grid The use of solar power in combination with the regional electric grid ensures operational sustainability 4,000 pallet positions in the storage temperature conditions of +15-25°C Future capacity for storage at -20°C and at +5°C Key Balerna Facility Capabilities Include: - Operation as an Open Bonded Warehouse: The open bonded warehouse designation enables streamlined handling of regulated and high-value goods The designation provides a significant strategic advantage for enabling strict regulatory compliance - Successful Regulatory Certification: The Balerna Switzerland facility is GDP certified by the Swiss Agency for Therapeutic Products (Swissmedic) ensuring operations deliver the highest standards of quality and compliance - Import & Export Authorization: The site is fully authorized to handle the import and export of client products and manage related product warehousing activities Advantages of storing with Singota in Balerna include streamlined import and export processes Switzerland site is fully authorized to handle import and export of life science products and manage related supply chain activities The new site benefits from expertise gained across Singota’s 20-year history of operational excellence and Singota’s track record of 6 years of successful operation in Europe The Balerna facility stands ready to deliver highly reliable storage and logistics services for life science clients worldwide combines operational excellence with sustainability offering clients confidence that their products are handled with the utmost care and attention,” said Travis Hudson “After many months of work and thoughtful diligence Singota and our European team have delivered an outstanding new addition to Singota’s global portfolio of cGMP and GDP compliant supply chain logistics solutions.” This expansion complements Singota’s existing European capabilities and highlights its role as a trusted partner for pharmaceutical and life science companies If your company seeks tailored global logistics solutions for materials and products intended for use across development Singota Solutions is a Contract Development and Manufacturing Organization (CDMO) headquartered in Bloomington specializing in sterile drug product development including formulation process and analytical method development; scale-up and cGMP sterile products manufacture Singota delivers tailored solutions to accelerate drug development pipelines worldwide For more information on Singota’s expanded European capabilities, please visit www.singota.com or contact us at solutions@singota.com The Daily Rundown is published Monday through Friday and gives you a quick look at the day's top stories Friday's weekly recap will let you catch up on the most important and most popular stories of the week Find out what the IDS is saying about IU basketball distributed during the IU basketball season By: Charlie Sternberg Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced except with the prior written permission of Rodman Media Please enable JS and disable any ad blocker